Zijian Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zijian Zhao has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Yan Lian
School of Chemistry and Materials Science, Huaihua University, Huaihua, P.R. China
3 shared publicationsAnguo Hou
School of Chinese Traditional Medicine Yunnan University of Traditional Chinese Medicine Yuhua Rd. 1076 650500 Kunming Yunnan P. R. China
2 shared publications- Hao Wei
School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi Province, China
2 shared publications - Jinsheng Li
Department of Pharmacology, Shaanxi University of Chinese Medicine, Xianyang 712046, China
2 shared publications Qiao Zhu
College of Pharmacy, Shaanxi University of Chinese Medicine, Shaanxi, P.R. China
2 shared publicationsShiying Che
College of Pharmacy, Shaanxi University of Chinese Medicine, Shaanxi, P.R. China
2 shared publications
Latest Publications
- 12 February 2026
- Published by Springer Nature in Microchimica Acta
- Vol. 193 (3) , 155
Dual-template engineered 2D UiO-66-derived carbon nanosheets toward ultrasensitive electrochemical sensing of luteolin
- 12 February 2026
- Published by Springer Nature in Microchimica Acta
- Vol. 193 (3) , 155
Dual-template engineered 2D UiO-66-derived carbon nanosheets toward ultrasensitive electrochemical sensing of luteolin
- 14 January 2026
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 151 (3) , 913-923
Cobalt nanoparticle-encapsulated N-doped carbon nanotubes on 3D porous carbon: a novel platform for ultrasensitive electrochemical sensing of rutin
This work develops an ultrasensitive electrochemical sensor for detecting rutin (Rt) using a composite material, Co@N-CNTs/3DHC. The composite integrates cobalt-encapsulated, nitrogen-doped carbon nanotubes within a three-dimensional porous carbon framework. We synthesized the material through a controlled pyrolysis method. First, cobalt-based metal–organic frameworks were grown in situ on the 3DHC substrate. The addition of dicyandiamide (DCDA) helped direct the morphology, and the 3DHC structure itself effectively suppressed precursor aggregation. This process yielded a uniform network of nitrogen-doped carbon nanotubes (N-CNTs) with diameters near 100 nm, inside which ultrafine cobalt nanoparticles (NPs) were confined. The integrated N-CNTs and 3DHC framework creates a hierarchical porous architecture that promotes efficient mass transport. In addition, the well-dispersed Co NPs substantially improve both electrical conductivity and electrocatalytic activity. Under optimized conditions, the Co@N-CNTs/3DHC/GCE exhibited two well-defined linear ranges from 0.1 to 50 nM and from 50 to 1000 nM, achieving an ultralow detection limit (LOD) of 0.04 nM. Furthermore, it was successfully applied to accurately determine the rutin content in real samples, including buckwheat and rutin tablets, yielding satisfactory recoveries (96.0% to 105.0%). This work provides a novel strategy for developing highly sensitive and stable methods for rutin detection, demonstrating significant potential for practical applications in pharmaceutical quality control and biomedical analysis.
- 14 January 2026
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 151 (3) , 913-923
Cobalt nanoparticle-encapsulated N-doped carbon nanotubes on 3D porous carbon: a novel platform for ultrasensitive electrochemical sensing of rutin
This work develops an ultrasensitive electrochemical sensor for detecting rutin (Rt) using a composite material, Co@N-CNTs/3DHC. The composite integrates cobalt-encapsulated, nitrogen-doped carbon nanotubes within a three-dimensional porous carbon framework. We synthesized the material through a controlled pyrolysis method. First, cobalt-based metal–organic frameworks were grown in situ on the 3DHC substrate. The addition of dicyandiamide (DCDA) helped direct the morphology, and the 3DHC structure itself effectively suppressed precursor aggregation. This process yielded a uniform network of nitrogen-doped carbon nanotubes (N-CNTs) with diameters near 100 nm, inside which ultrafine cobalt nanoparticles (NPs) were confined. The integrated N-CNTs and 3DHC framework creates a hierarchical porous architecture that promotes efficient mass transport. In addition, the well-dispersed Co NPs substantially improve both electrical conductivity and electrocatalytic activity. Under optimized conditions, the Co@N-CNTs/3DHC/GCE exhibited two well-defined linear ranges from 0.1 to 50 nM and from 50 to 1000 nM, achieving an ultralow detection limit (LOD) of 0.04 nM. Furthermore, it was successfully applied to accurately determine the rutin content in real samples, including buckwheat and rutin tablets, yielding satisfactory recoveries (96.0% to 105.0%). This work provides a novel strategy for developing highly sensitive and stable methods for rutin detection, demonstrating significant potential for practical applications in pharmaceutical quality control and biomedical analysis.
- Open Access
Semi-Synthesis and Biological Evaluation of Novel Sinomenine Derivatives
Sinomenine has long been known as an anti-inflammatory drug, while poor efficiency and large-dose treatment had limited its further application. Five novel sinomenine 1-Br-4-cinnamic acid esters derivatives 2a–2e were designed and synthesized to improve its analgesic and anti-inflammatory activity. All synthesized sinomenine derivatives were structurally confirmed by NMR and ESI-MS. Molecular docking results showed that compounds 2a–2e had stable binding to the GBP5 protein. The compounds 2a–2e showed stable binding to the GBP5 protein by molecular docking Pre-preparing the druggability of compounds 2a–2e by ADEMT 3.0 showed that each derivative had similar druggability to sinomenine. The analgesic activity of compounds 2a–2e was preliminarily determined by hot plate and acetic acid writhing experiments, while anti-neuroinflammatory effects were evaluated by a xylene-induced mouse ear edema model. The results of the hot plate method showed that the synthesized sinomenine derivatives 2a–2e had some analgesic effects. The results of the acetic acid writhing test showed that the analgesic effects of 2a, 2c, 2e were better than that of sinomenine, and the other derivatives were equivalent to sinomenine. Compound 2b showed excellent anti-inflammatory properties in mouse ear edema.
Open AccessSemi-Synthesis and Biological Evaluation of Novel Sinomenine Derivatives
Sinomenine has long been known as an anti-inflammatory drug, while poor efficiency and large-dose treatment had limited its further application. Five novel sinomenine 1-Br-4-cinnamic acid esters derivatives 2a–2e were designed and synthesized to improve its analgesic and anti-inflammatory activity. All synthesized sinomenine derivatives were structurally confirmed by NMR and ESI-MS. Molecular docking results showed that compounds 2a–2e had stable binding to the GBP5 protein. The compounds 2a–2e showed stable binding to the GBP5 protein by molecular docking Pre-preparing the druggability of compounds 2a–2e by ADEMT 3.0 showed that each derivative had similar druggability to sinomenine. The analgesic activity of compounds 2a–2e was preliminarily determined by hot plate and acetic acid writhing experiments, while anti-neuroinflammatory effects were evaluated by a xylene-induced mouse ear edema model. The results of the hot plate method showed that the synthesized sinomenine derivatives 2a–2e had some analgesic effects. The results of the acetic acid writhing test showed that the analgesic effects of 2a, 2c, 2e were better than that of sinomenine, and the other derivatives were equivalent to sinomenine. Compound 2b showed excellent anti-inflammatory properties in mouse ear edema.
- Open Access
Synthesis of New Derivatives of Berberine Canagliflozin and Study of Their Antibacterial Activity and Mechanism
The isoquinoline alkaloid berberine, derived from Coptidis rhizoma, exhibits antibacterial, hypoglycemic, and anti-inflammatory properties. Canagliflozin is a sodium–glucose cotransporter 2 (SGLT2) inhibitor. We synthesized compounds B9OC and B9OBU by conjugating canagliflozin and n-butane at the C9 position of berberine, aiming to develop antimicrobial agents for combating bacterial infections worldwide. We utilized clinically prevalent pathogenic bacteria, namely Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, to investigate the antibacterial efficacy of B9OC. This was accomplished through the determination of the MIC80 values, analysis of bacterial growth curves, evaluation of biofilm formation using crystal violet staining, assessment of impact on bacterial proteins via SDS-PAGE analysis, and observation of alterations in bacterial morphology utilizing field emission scanning electron microscopy. Meanwhile, the ADMET of compound B9OC was predicted using a computer-aided method. The findings revealed that B9OC exhibited lower minimal inhibitory concentrations against all three bacteria compared to berberine alone or in combination with canagliflozin. The minimal inhibitory concentrations (MICs) of B9OC against the three experimental strains were determined to be 0.035, 0.258, and 0.331 mM. However, B9OBu exhibited a lower level of antimicrobial activity compared to berberine. The compound B9OC exhibits a broad spectrum of antibacterial activity by disrupting the integrity of bacterial cell walls, leading to cellular rupture and the subsequent degradation of intracellular proteins.
Open AccessSynthesis of New Derivatives of Berberine Canagliflozin and Study of Their Antibacterial Activity and Mechanism
The isoquinoline alkaloid berberine, derived from Coptidis rhizoma, exhibits antibacterial, hypoglycemic, and anti-inflammatory properties. Canagliflozin is a sodium–glucose cotransporter 2 (SGLT2) inhibitor. We synthesized compounds B9OC and B9OBU by conjugating canagliflozin and n-butane at the C9 position of berberine, aiming to develop antimicrobial agents for combating bacterial infections worldwide. We utilized clinically prevalent pathogenic bacteria, namely Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, to investigate the antibacterial efficacy of B9OC. This was accomplished through the determination of the MIC80 values, analysis of bacterial growth curves, evaluation of biofilm formation using crystal violet staining, assessment of impact on bacterial proteins via SDS-PAGE analysis, and observation of alterations in bacterial morphology utilizing field emission scanning electron microscopy. Meanwhile, the ADMET of compound B9OC was predicted using a computer-aided method. The findings revealed that B9OC exhibited lower minimal inhibitory concentrations against all three bacteria compared to berberine alone or in combination with canagliflozin. The minimal inhibitory concentrations (MICs) of B9OC against the three experimental strains were determined to be 0.035, 0.258, and 0.331 mM. However, B9OBu exhibited a lower level of antimicrobial activity compared to berberine. The compound B9OC exhibits a broad spectrum of antibacterial activity by disrupting the integrity of bacterial cell walls, leading to cellular rupture and the subsequent degradation of intracellular proteins.
- Open Access
- 8 November 2022
- Published by Elsevier in Global Energy Interconnection
- Vol. 5 (5) , 531-542
Synergies of carbon neutrality, air pollution control, and health improvement — a case study of China energy interconnection scenario
- 8 November 2022
- Published by Elsevier in Global Energy Interconnection
- Vol. 5 (5) , 531-542
Open AccessSynergies of carbon neutrality, air pollution control, and health improvement — a case study of China energy interconnection scenario
- Open Access
Synthesis of Berberine and Canagliflozin Chimera and Investigation into New Antibacterial Activity and Mechanisms
Berberine is an isoquinoline alkaloid isolated from Chinese herbal medicines such as Coptis chinensis. It has many pharmacological actions, such as antibacterial, hypoglycemic, anti-inflammatory, and so on. However, due to the low lipophilicity of berberine, it is difficult to penetrate the bacterial cell membrane and also difficult to be absorbed orally and usually needs a relatively high dose to achieve the ideal effect. The purpose of this study is to transform the structure of berberine in order to improve the bioavailability of berberine and reduce the dosage. Moreover, we introduce a pharmacophore named Canagliflozin, a hypoglycemic drug (which was also found to have potential anti-bacterial activity) into BBR to see whether this new compound has more existed activities. We at first connected berberine with Canagliflozin, to form a new compound (BC) and see whether BC has synergic effects. We use microbroth dilution method to determine the minimum inhibitory concentration of BC, determine the bacterial growth with the enzyme labeling instrument, observe the formation of bacterial biofilm with crystal violet staining method, observe the bacterial morphology with field emission scanning electron microscope, and determine the intracellular protein with SDS-PAGE. The above indicators reflect the damage of BC to bacteria. New compound BC was successfully obtained by chemical synthesis. The minimal inhibitory concentration of compound BC on three bacteria was significantly better than that of berberine and canagliflozin alone and the combination of berberine and canagliflozin. Moreover, compound BC has obvious destructive effect on bacterial morphology and biofilm, and the compound also has destructive effect on intracellular proteins. Therefore, new compound BC has broad-spectrum antibacterial activity and the inhibitory effect of BC might play a role by destroying the integrity of biofilm and the intracellular protein of bacteria. In conclusion, we create a new molecular entity of berberine and Canagliflozin chimera and open up a new prospect for berberine derivatives in the treatment of bacterial infection.
Open AccessSynthesis of Berberine and Canagliflozin Chimera and Investigation into New Antibacterial Activity and Mechanisms
Berberine is an isoquinoline alkaloid isolated from Chinese herbal medicines such as Coptis chinensis. It has many pharmacological actions, such as antibacterial, hypoglycemic, anti-inflammatory, and so on. However, due to the low lipophilicity of berberine, it is difficult to penetrate the bacterial cell membrane and also difficult to be absorbed orally and usually needs a relatively high dose to achieve the ideal effect. The purpose of this study is to transform the structure of berberine in order to improve the bioavailability of berberine and reduce the dosage. Moreover, we introduce a pharmacophore named Canagliflozin, a hypoglycemic drug (which was also found to have potential anti-bacterial activity) into BBR to see whether this new compound has more existed activities. We at first connected berberine with Canagliflozin, to form a new compound (BC) and see whether BC has synergic effects. We use microbroth dilution method to determine the minimum inhibitory concentration of BC, determine the bacterial growth with the enzyme labeling instrument, observe the formation of bacterial biofilm with crystal violet staining method, observe the bacterial morphology with field emission scanning electron microscope, and determine the intracellular protein with SDS-PAGE. The above indicators reflect the damage of BC to bacteria. New compound BC was successfully obtained by chemical synthesis. The minimal inhibitory concentration of compound BC on three bacteria was significantly better than that of berberine and canagliflozin alone and the combination of berberine and canagliflozin. Moreover, compound BC has obvious destructive effect on bacterial morphology and biofilm, and the compound also has destructive effect on intracellular proteins. Therefore, new compound BC has broad-spectrum antibacterial activity and the inhibitory effect of BC might play a role by destroying the integrity of biofilm and the intracellular protein of bacteria. In conclusion, we create a new molecular entity of berberine and Canagliflozin chimera and open up a new prospect for berberine derivatives in the treatment of bacterial infection.
- 28 December 2020
- Published by Taylor & Francis in Synthetic Communications
- Vol. 51 (6) , 1-11
Copper-catalyzed oxidative methylation of sulfonamides by dicumyl peroxide
A novel and facile copper-catalyzed methylation of sulfonamides was herein demonstrated. The practical transformation took place readily under the oxidative conditions, and N-methyl amides (23 examples) were successfully furnished in high efficiency (up to 90% yields). Dicumyl peroxide was considered to act not only as the oxidant in the system, but also methyl donor for the methylation protocol. Graphical Abstract
- 28 December 2020
- Published by Taylor & Francis in Synthetic Communications
- Vol. 51 (6) , 1-11
Copper-catalyzed oxidative methylation of sulfonamides by dicumyl peroxide
A novel and facile copper-catalyzed methylation of sulfonamides was herein demonstrated. The practical transformation took place readily under the oxidative conditions, and N-methyl amides (23 examples) were successfully furnished in high efficiency (up to 90% yields). Dicumyl peroxide was considered to act not only as the oxidant in the system, but also methyl donor for the methylation protocol. Graphical Abstract
- 16 June 2020
- Published by Taylor & Francis in Synthetic Communications
- Vol. 50 (15) , 2338-2346
Palladium/nickel-mediated cross coupling reaction between phosphorylamides and alkenes toward enephosphorylamides
Enephosphorylamides were herein successfully prepared from phosphorylamides and substituted alkenes. The dehydrogenative transformation took place in the presence of a combination of a palladium diacetate and nickel dichloride. The transition metal-catalyzed methodology enjoyed high efficiency and broad substrate scope. Moreover, a plausible mechanism was proposed for the oxidative C–N cross coupling protocol.
- 16 June 2020
- Published by Taylor & Francis in Synthetic Communications
- Vol. 50 (15) , 2338-2346
Palladium/nickel-mediated cross coupling reaction between phosphorylamides and alkenes toward enephosphorylamides
Enephosphorylamides were herein successfully prepared from phosphorylamides and substituted alkenes. The dehydrogenative transformation took place in the presence of a combination of a palladium diacetate and nickel dichloride. The transition metal-catalyzed methodology enjoyed high efficiency and broad substrate scope. Moreover, a plausible mechanism was proposed for the oxidative C–N cross coupling protocol.
- 11 December 2018
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2018 (48) , 6857-6866
Copper‐Catalyzed (Di)Arylmethylation of Phosphorylamides Under Oxidative Conditions
A compatible and practical (di)arylmethylation of phosphorylamides was successfully accessed in the presence of copper iodide as the catalyst, azodiisobutyronitrile as the radical initiator, and di‐tert‐butyl peroxide as the oxidant. Both methylarenes and diaryl methanes were compatible under the oxidative conditions, enjoying broad functional groups tolerance (51 examples) and good efficiency (up to 90 % yields).
- 11 December 2018
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2018 (48) , 6857-6866
Copper‐Catalyzed (Di)Arylmethylation of Phosphorylamides Under Oxidative Conditions
A compatible and practical (di)arylmethylation of phosphorylamides was successfully accessed in the presence of copper iodide as the catalyst, azodiisobutyronitrile as the radical initiator, and di‐tert‐butyl peroxide as the oxidant. Both methylarenes and diaryl methanes were compatible under the oxidative conditions, enjoying broad functional groups tolerance (51 examples) and good efficiency (up to 90 % yields).
- 1 January 2018
- Published by Taylor & Francis in Synthetic Communications
- Vol. 48 (12) , 1436-1442
Palladium-catalyzed desulfitative arylation of sulfonamides with sodium arylsulfinates
A Pd(II)-catalyzed desulfitative arylation protocol between sulfonamides and sodium arylsulfinates was herein reported. The direct arylation reaction was successfully achieved by a Pd(II)/Ag(I)-mediated system without participation of any external ligands with a release of SO2. And different N-aryl sulfonamides were obtained readily in up to 86% yields, exhibiting good functional groups tolerance (25 examples). [GRAPHICS] .
- 1 January 2018
- Published by Taylor & Francis in Synthetic Communications
- Vol. 48 (12) , 1436-1442
Palladium-catalyzed desulfitative arylation of sulfonamides with sodium arylsulfinates
A Pd(II)-catalyzed desulfitative arylation protocol between sulfonamides and sodium arylsulfinates was herein reported. The direct arylation reaction was successfully achieved by a Pd(II)/Ag(I)-mediated system without participation of any external ligands with a release of SO2. And different N-aryl sulfonamides were obtained readily in up to 86% yields, exhibiting good functional groups tolerance (25 examples). [GRAPHICS] .